MedPath

Carmustine

These highlights do not include all the information needed to use CARMUSTINE FOR INJECTION safely and effectively. See full prescribing information for CARMUSTINE FOR INJECTION. CARMUSTINE for injection, for intravenous use Initial U.S. Approval: 1977

Approved
Approval ID

db5d5fec-1ebc-492a-8987-a5f449fd08a1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 17, 2022

Manufacturers
FDA

STI Pharma LLC

DUNS: 832714070

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carmustine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54879-036
Application NumberANDA209278
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carmustine
Product Specifications
Effective DateNovember 17, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carmustine - FDA Drug Approval Details